sICAM-1Soluble Inter-cellular Adhesion Molecule-1
References in periodicals archive ?
A large number of inflammato-ry factors such as TNF-[alpha], CRP, sICAM-1 and IFN-I3 are secreted into the blood circulation.
Ademas, HFD presento disminucion significativa de adiponectina (p <0,05), y aumento de biomarcadores de lipidemia, glucemia, inflamacion, estres oxidativo, lesion vascular como la molecula de adhesion intercelular soluble 1 (sICAM-1), proteina de adhesion de celulas vasculares soluble 1 (sVCAM-1), endotelina 1 (ET-1), y la coagulacion y la trombosis, como el factor de Von Willebrand (vWF), y el inhibidor del activador del plasminogeno-1 (PAI -1), en comparacion con los niveles normales de estos parametros en el grupo de control.
[30] evaluated 37 patients with sudden SNHL and indicated the role of elevated sICAM-1 and sVACM-1 levels in these patients.
We located and identified 101 members of the original cohort from the Yugoslavia study of environmental lead, pregnancy outcomes, and child development and requested their participation in a follow-up study, in which each participant would be evaluated once to assess their BPb, BP, and serum sICAM-1 and sVCAM-1.
Moreover, COCs containing the progestins CPA and CMA did not significantly change sICAM-1, sVICAm-1, and selectins.
[70] controlled American vegetable- arrow] clinical adults, with derived n-3 sICAM-1, trial metabolic IL-6, and syndrome monocyte chemoattrac- tant protein in all three groups Subgroup 1: No low dose (2.2 beneficial g/d of n-3) independent Subgroup 2: effect of high dose (6.6 dose or g/d of n-3) source Group 2: sea- derived n-3 Subgroup 1: low dose (1.2 g/d) Subgroup 2: high dose (3.6 g/d) Group 3: placebo Duration: 8 weeks Malekshahi Double- 84 (42M/ Group 1: 3 n- Group 1: Moghadam blind, 42W) 3 capsules/ [down arrow] et al.
The release of MCP-1, sICAM-1, and sVCAM-1 was performed by sandwich ELISA from R&D Systems (Minneapolis, MN, USA) according to the manufacturer's instructions.
As shown in the figure, blockade of IL-6 signaling lead to a broad range of changes in biomarkers such as sICAM-1, VEGF, osteonectin, osteopontin, osteocalcin, and bone alkaline phosphatase.
This includes leukocyte count, (47) markers of leukocyte activation such as myeloperoxidase (48), cytokines such as interleukin-6 (49), adhesion molecules such as soluble intercellular adhesion molecule 1 (sICAM-1) and P-selectin (50), and markers associated with lipid oxidation such as lipoprotein-associated phospholipase A2 (Lp-PLA2) (51) and pregnancy-associated plasma protein (PAPP) A (52).
Jinnouchi, "The activity of carotidynia syndrome is correlated with the soluble intracellular adhesion molecule-1 (sICAM-1) level," Southern Medical Journal, vol.
Borawska, "Soluble intercellular adhesion molecule-1 (sICAM-1): an overview," European Cytokine Network, vol.